Aliases & Classifications for Dermatitis

Summaries for Dermatitis

MedlinePlus : 41 eczema is a term for several different types of skin swelling. eczema is also called dermatitis. most types cause dry, itchy skin and rashes on the face, inside the elbows and behind the knees, and on the hands and feet. scratching the skin can cause it to turn red, and to swell and itch even more. eczema is not contagious. the cause is not known. it is likely caused by both genetic and environmental factors. eczema may get better or worse over time, but it is often a long-lasting disease. people who have it may also develop hay fever and asthma. the most common type of eczema is atopic dermatitis. it is most common in babies and children but adults can have it too. as children who have atopic dermatitis grow older, this problem may get better or go away. but sometimes the skin may stay dry and get irritated easily. treatments may include medicines, skin creams, light therapy, and good skin care. you can prevent some types of eczema by avoiding things that irritate your skin, such as certain soaps, fabrics, and lotions stress things you are allergic to, such as food, pollen, and animals nih: national institute of arthritis and musculoskeletal and skin diseases

MalaCards based summary : Dermatitis, also known as eczema, is related to asthma and exogenous ochronosis, and has symptoms including exanthema and pruritus. An important gene associated with Dermatitis is FLG (Filaggrin), and among its related pathways/superpathways are Cytokine Signaling in Immune system and IL-17 Family Signaling Pathways. The drugs Montelukast and Petrolatum have been mentioned in the context of this disorder. Affiliated tissues include skin, testes and breast, and related phenotypes are Increased shRNA abundance (Z-score > 2) and immune system

Disease Ontology : 12 A skin disease characterized by itchy, erythematous, vesicular, weeping and crusting patches of skin.

Wikipedia : 72 Dermatitis, also known as eczema, is a group of diseases that results in inflammation of the skin. These... more...

Related Diseases for Dermatitis

Diseases related to Dermatitis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 624)
id Related Disease Score Top Affiliating Genes
1 asthma 31.1 CCL11 CCL17 CCL22 FLG IGHE IL13
2 exogenous ochronosis 30.3 FLG IGHE
3 churg-strauss syndrome 29.9 CCL17 FLG IL31 IL4
4 epidermolysis bullosa 25.0 BCL7B CCL11 CCL17 CCL22 CCL27 CMA1
5 atopic dermatitis 12.4
6 contact dermatitis 12.3
7 allergic contact dermatitis 12.3
8 seborrheic dermatitis 12.3
9 dermatitis herpetiformis 12.3
10 irritant dermatitis 12.2
11 cercarial dermatitis 12.2
12 seborrheic infantile dermatitis 12.1
13 chronic actinic dermatitis 12.1
14 seborrhea-like dermatitis with psoriasiform elements 12.1
15 contagious pustular dermatitis 12.0
16 autoimmune progesterone dermatitis 12.0
17 dermatitis, atopic 2 12.0
18 interstitial granulomatous dermatitis with arthritis 12.0
19 microcephaly, congenital cataract, and psoriasiform dermatitis 12.0
20 infective dermatitis associated with htlv-1 12.0
21 atopic dermatitis 3 11.9
22 exfoliative dermatitis 11.9
23 occupational dermatitis 11.9
24 toxicodendron dermatitis 11.9
25 atopic dermatitis 5 11.9
26 atopic dermatitis 6 11.9
27 atopic dermatitis 7 11.9
28 atopic dermatitis 4 11.9
29 phototoxic dermatitis 11.9
30 photoallergic dermatitis 11.9
31 granulomatous dermatitis 11.8
32 atopic dermatitis 8 11.8
33 atopic dermatitis 9 11.8
34 immunodeficiency 11b with atopic dermatitis 11.8
35 juvenile dermatitis herpetiformis 11.8
36 spongiotic dermatitis 11.8
37 dermatitis herpetiformis, familial 11.8
38 agammaglobulinemia, microcephaly, and severe dermatitis 11.7
39 eczema herpeticum 11.7
40 allergic contact dermatitis of eyelid 11.7
41 acneiform dermatitis 11.7
42 eczematous dermatitis of eyelid 11.6
43 blau syndrome 11.5
44 neurotic excoriation 11.5
45 erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis, and hyper ige 11.4
46 subcorneal pustular dermatosis 11.2
47 pompholyx 11.2
48 acrodermatitis enteropathica 11.2
49 acrodermatitis 11.1
50 netherton syndrome 11.1

Graphical network of the top 20 diseases related to Dermatitis:



Diseases related to Dermatitis

Symptoms & Phenotypes for Dermatitis

UMLS symptoms related to Dermatitis:


exanthema, pruritus

GenomeRNAi Phenotypes related to Dermatitis according to GeneCards Suite gene sharing:

26
id Description GenomeRNAi Source Accession Score Top Affiliating Genes
1 Increased shRNA abundance (Z-score > 2) GR00366-A-105 9.58 MSMO1
2 Increased shRNA abundance (Z-score > 2) GR00366-A-11 9.58 IL13
3 Increased shRNA abundance (Z-score > 2) GR00366-A-128 9.58 IL13
4 Increased shRNA abundance (Z-score > 2) GR00366-A-130 9.58 IL13
5 Increased shRNA abundance (Z-score > 2) GR00366-A-152 9.58 MSMO1
6 Increased shRNA abundance (Z-score > 2) GR00366-A-161 9.58 MSMO1
7 Increased shRNA abundance (Z-score > 2) GR00366-A-186 9.58 NACA
8 Increased shRNA abundance (Z-score > 2) GR00366-A-199 9.58 FAF2 IL13 MSMO1 NACA
9 Increased shRNA abundance (Z-score > 2) GR00366-A-21 9.58 MSMO1
10 Increased shRNA abundance (Z-score > 2) GR00366-A-22 9.58 FAF2
11 Increased shRNA abundance (Z-score > 2) GR00366-A-32 9.58 NACA
12 Increased shRNA abundance (Z-score > 2) GR00366-A-39 9.58 IL13
13 Increased shRNA abundance (Z-score > 2) GR00366-A-57 9.58 FAF2 MSMO1
14 Increased shRNA abundance (Z-score > 2) GR00366-A-6 9.58 NACA

MGI Mouse Phenotypes related to Dermatitis:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 immune system MP:0005387 9.28 CCL11 CCL17 CMA1 IL13 IL31RA IL4

Drugs & Therapeutics for Dermatitis

Drugs for Dermatitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 530)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Montelukast Approved Phase 4 158966-92-8 5281040
2
Petrolatum Approved Phase 4,Phase 3,Phase 1,Phase 2 8009-03-8
3
Bacitracin Approved, Vet_approved Phase 4,Phase 3,Phase 2 1405-87-4 439542 10909430
4
Hydrocortisone Approved, Vet_approved Phase 4,Phase 3,Phase 2 50-23-7 5754 657311
5
Ciclopirox Approved, Investigational Phase 4,Phase 3 29342-05-0 2749
6
Isotretinoin Approved Phase 4,Phase 3 4759-48-2 5538 5282379
7
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 22916-47-8 4189
8
Salicylic acid Approved, Vet_approved Phase 4 69-72-7 338
9
Glycerol Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 56-81-5 753
10
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
11
Triamcinolone Approved, Vet_approved Phase 4,Phase 2 124-94-7 31307
12
Cetuximab Approved Phase 4,Phase 3,Phase 2 205923-56-4 56842117 2333
13
Omalizumab Approved, Investigational Phase 4,Phase 2,Phase 1 242138-07-4
14
Desonide Approved, Investigational Phase 4,Phase 3 638-94-8 5311066
15
Histamine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 75614-87-8, 51-45-6 774
16
Ethanol Approved Phase 4,Phase 3,Phase 1 64-17-5 702
17
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 83-43-2 6741
18
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 50-24-8 5755
19
Povidone Approved Phase 4,Phase 3,Phase 2 9003-39-8
20
Zinc Approved Phase 4,Phase 3,Phase 2 7440-66-6 32051 23994
21
Zinc oxide Approved Phase 4,Phase 3,Phase 2 1314-13-2
22
Betamethasone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1 378-44-9 9782
23
Ephedrine Approved Phase 4,Phase 2 299-42-3 9294
24
Pseudoephedrine Approved Phase 4,Phase 2 90-82-4 7028
25
Menthol Approved Phase 4,Phase 3,Phase 2 2216-51-5 16666
26
Dapsone Approved, Investigational Phase 4 80-08-0 2955
27
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 137071-32-0 6447131 17753757
28
Fluocinonide Approved, Investigational Phase 4 356-12-7 9642
29
Cortisone acetate Approved Phase 4,Phase 2 1950-04-4, 50-04-4 5745
30
Cetirizine Approved Phase 4,Phase 3,Phase 2,Phase 1 83881-51-0 2678
31
Levocetirizine Approved Phase 4,Phase 3,Phase 1 130018-77-8
32
Mupirocin Approved, Investigational, Vet_approved Phase 4 12650-69-0 446596
33
Ketoconazole Approved, Investigational Phase 4,Phase 3 65277-42-1 47576 3823
34
Epinephrine Approved, Vet_approved Phase 4,Phase 2 51-43-4 5816
35 Racepinephrine Approved Phase 4,Phase 2
36
Benzocaine Approved Phase 4,Phase 3,Phase 1,Phase 2 1994-09-7, 94-09-7 2337
37
Adapalene Approved Phase 4,Phase 1 106685-40-9 60164
38
Benzoyl peroxide Approved Phase 4 94-36-0 7187
39
Clindamycin Approved, Vet_approved Phase 4 18323-44-9 29029
40
Adalimumab Approved Phase 4,Phase 2 331731-18-1 16219006
41
Celecoxib Approved, Investigational Phase 4 169590-42-5 2662
42
Sorafenib Approved, Investigational Phase 4,Phase 1 284461-73-0 216239 406563
43 Titanium dioxide Approved Phase 4 13463-67-7
44
Alitretinoin Approved, Investigational Phase 4,Phase 3 5300-03-8 444795
45
Triclosan Approved Phase 4 3380-34-5 5564
46
Desoximetasone Approved Phase 4 382-67-2 5311067
47
Cefuroxime Approved Phase 4 55268-75-2 5361202 5479529
48
Clotrimazole Approved, Vet_approved Phase 4 23593-75-1 2812
49
Calcitriol Approved, Nutraceutical Phase 4,Phase 2 32222-06-3 134070 5280453
50
Vitamin D Approved, Nutraceutical, Vet_approved Phase 4,Phase 3,Phase 2 1406-16-2

Interventional clinical trials:

(show top 50) (show all 1074)

id Name Status NCT ID Phase Drugs
1 Does Treatment With Montelukast Improve Symptoms of Atopic Dermatitis in Children? Unknown status NCT02534467 Phase 4 Montelukast
2 Efficacy of KAM2904 Face Cream and KAM3008 Body Lotion Treatment in Children With Atopic Dermatitis (AD) Unknown status NCT01781663 Phase 4
3 Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents Unknown status NCT01797562 Phase 4 T.R.U.E. Test Panel 3.2
4 Efficacy and Safety of Low-dose Oral Isotretinoin for Seborrhea Unknown status NCT01139749 Phase 4 oral isotretinoin;salicylic acid and ciclopirox olamine
5 Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation Unknown status NCT00779792 Phase 4 clobetasol;triamcinolone acetonide;tacrolimus;glycerol;vehicle ointment (paraffin oil/soft white paraffin)
6 Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) Unknown status NCT01553032 Phase 4 Erbitux®
7 Quaternium-15, Use Test Unknown status NCT00311454 Phase 4 T.R.U.E.Test
8 Role of Anti-IgE in Severe Childhood Eczema Unknown status NCT02300701 Phase 4 Xolair;Placebo
9 The Randomized Controlled Clinical Trial of Kushen Injection Unknown status NCT02346318 Phase 4 Compound Kushen Injection
10 Effect of Moisturizing Creams on Skin Barrier Function Unknown status NCT00771121 Phase 4 urea/lactic acid;Placebo
11 Effects of Pimecrolimus Cream 1% on the Molecular and Cellular Profile of Adult Male Patients With Atopic Dermatitis Completed NCT00117377 Phase 4 Pimecrolimus;Placebo
12 A Study Evaluating the Efficacy of Fluocinonide Cream 0.1% (Vanos) in Subjects With Atopic Dermatitis Completed NCT01049243 Phase 4 Fluocinonide Cream 0.1%
13 Open Label Study of Long Term Treatment of Pediatric Treatment of Atopic Dermatitis With Pimecrolimus Cream 1% Within a Usual Clinical Setting Completed NCT00509990 Phase 4 Pimecrolimus
14 Comparison of Pimecrolimus Cream 1% Twice-Daily to Once-Daily Dosing in the Management of Atopic Dermatitis in Pediatric Subjects Completed NCT00139581 Phase 4 Pimecrolimus;Pimecrolimus
15 Efficacy and Tolerability of New Topical Formulations in Subjects With Atopic Dermatitis Completed NCT02732314 Phase 4 Investigational OTC Cream;0.05% Desonide Cream
16 Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic Dermatitis Completed NCT00693693 Phase 4 hydrocortisone 17-butyrate 0.1% Cream preparation;hydrocortisone 17-butyrate 0.1% Ointment preparation;hydrocortisone 17-butyrate 0.1% Lipocream preparation
17 Elidel-Study: Elidel in Patients With Atopic Dermatitis Completed NCT00180141 Phase 4 Elidel-Creme
18 Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis Completed NCT00832585 Phase 4 Alefacept
19 Efficacy Study of Montelukast in Atopic Dermatitis Induced by Food Allergens Completed NCT00557284 Phase 4 Montelukast;Placebo
20 Epiceram™ Device Versus Mid-Strength Topical Steroid (Fluticasone Propionate 0.05%) for Treatment of Atopic Dermatitis Completed NCT00616538 Phase 4 Fluticasone Propionate 0.05%
21 A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis Completed NCT00666302 Phase 4 tacrolimus ointment;pimecrolimus cream
22 A Clinical Study in Children and Adolescents With Mild to Moderate Atopic Dermatitis Completed NCT00568412 Phase 4 Elidel
23 Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis Completed NCT00666159 Phase 4 tacrolimus ointment;pimecrolimus cream
24 Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis Completed NCT00667160 Phase 4 tacrolimus ointment;pimecrolimus cream
25 Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit Completed NCT00654355 Phase 4 tacrolimus ointment
26 Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis Completed NCT00667056 Phase 4 tacrolimus ointment;placebo ointment
27 Efficacy of Desonide (Desonatetm) Gel 0.05% in Younger and Older Subjects With Atopic Dermatitis Completed NCT00690833 Phase 4 topical desonide hydrogel 0.05%
28 An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis Completed NCT01828879 Phase 4 Tacrolimus
29 An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis Completed NCT01782729 Phase 4 Tacrolimus
30 Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis. Completed NCT01177566 Phase 4 pimecrolimus
31 Epiceram Versus Elidel for Treatment of Mild to Moderate Atopic Dermatitis Completed NCT00460083 Phase 4 Elidel(R) (pimecrolimus 1%)
32 Pimecrolimus Cream 1% Plus Topical Corticosteroid in Patients (2-17 Years of Age) With Severe Atopic Dermatitis Completed NCT00121381 Phase 4 Pimecrolimus plus topical corticosteroid (TCS);Pimecrolimus vehicle (Placebo) plus topical corticosteroid (TCS)
33 Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application Completed NCT01063218 Phase 4
34 Management of Pruritus With Xyzal in Atopic Dermatitis Completed NCT00884325 Phase 4 Levocetirizine dihydrochloride (Xyzal);placebo
35 Efficacy and Safety of Pimecrolimus Cream 1% in Patients (2 to 11 Years Old) With Mild to Moderate Facial Atopic Dermatitis Completed NCT00130364 Phase 4 Pimecrolimus;Placebo
36 Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis Completed NCT01591070 Phase 4 Tacrolimus;Tacrolimus
37 Analysis of the Quality of Life, the Clinical Effectiveness and Cost-effectiveness of a Novel Educational Programme in Patients With Psoriasis and Atopic Dermatitis Completed NCT01077882 Phase 4
38 Locobase® REPAIR Used as an Adjunctive to Standard Therapy in Children With Moderate to Severe Atopic Dermatitis Completed NCT00673725 Phase 4 Locobase® REPAIR
39 A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis Completed NCT00106496 Phase 4 Protopic;Corticosteroid;placebo
40 Ethanol-Free Clobetasol Propionate Foam 0.05% (Olux-E Foam) vs Vehicle Foam in the Treatment of Chronic Hand Dermatitis. Completed NCT01323673 Phase 4 clobetasol propionate 0.05%;Vehicle / Placebo
41 Combination Therapy for Atopic Dermatitis Completed NCT00119158 Phase 4 Combination of pimecrolimus and fluticasone;pimecrolimus
42 Study to Determine the Effect of an Anti-IgE Agent on Inflammatory Cells in the Skin of Atopic Dermatitis Patients Completed NCT00822783 Phase 4 Omalizumab;Placebo
43 A Study to Investigate the Use of Hydrogel Vehicle in Maintaining the Skin Barrier in Persons With Atopic Dermatitis Completed NCT01065714 Phase 4 Hydrogel vehicle;Eucerin Lotion
44 Trial on Effectiveness Combined Probiotics in Atopic Dermatitis in Children Completed NCT02519556 Phase 4 Probiatop;Placebo
45 Safety and Efficacy of Pimecrolimus Cream 1% in Mild to Moderate Head and Neck Atopic Dermatitis (AD) Patients Completed NCT00121316 Phase 4 Pimecrolimus;Placebo
46 Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis Completed NCT01745159 Phase 4 tacrolimus
47 Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis Completed NCT02589392 Phase 4
48 The Impact of Treating Staphylococcus Aureus Infection and Colonization on the Clinical Severity of Atopic Dermatitis Completed NCT00179959 Phase 4 Sodium hypochlorite (bleach) baths;Mupirocin ointment;Water;Petrolatum Ointment
49 Comparison of the Efficacy and Safety of Two Topical Creams for Pediatric Atopic Dermatitis Completed NCT00828412 Phase 4 Desonide Cream 0.05%
50 STUDY TO ASSESS THE LONG-TERM SAFETY OF EXTINA (KETOCONAZOLE) FOAM, 2% Completed NCT00703846 Phase 4 Ketoconazole

Search NIH Clinical Center for Dermatitis

Inferred drug relations via UMLS 69 / NDF-RT 48 :


Cochrane evidence based reviews: dermatitis

Genetic Tests for Dermatitis

Genetic tests related to Dermatitis:

id Genetic test Affiliating Genes
1 Eczema 29

Anatomical Context for Dermatitis

MalaCards organs/tissues related to Dermatitis:

39
Skin, Testes, Breast, T Cells, Colon, Neutrophil, Eye

Publications for Dermatitis

Articles related to Dermatitis:

(show top 50) (show all 5333)
id Title Authors Year
1
Targeted Treatment of Atopic Dermatitis. ( 28528610 )
2017
2
Economic Evaluation of Dupilumab for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults. ( 28933010 )
2017
3
Occupational allergic contact dermatitis caused by tetracaine in an otorhinolaryngologist. ( 27957755 )
2017
4
Allergic Contact Dermatitis to 3-o-Ethyl-L-Ascorbic Acid in Skin-lightening Cosmetics. ( 28002235 )
2017
5
Contact dermatitis caused by tulips: identification of contact sensitizers in tulip workers of Kashmir Valley in North India. ( 28940507 )
2017
6
Interstitial Granulomatous Dermatitis with Granuloma Annulare-Like Pattern Following Liposuction. ( 28946733 )
2017
7
Evidence of regulatory myeloid dendritic cells and circulating inflammatory epidermal dendritic cells-like modulated by Toll-like receptors 2 and 7/8 in adults with atopic dermatitis. ( 28083892 )
2017
8
TWEAK mediates inflammation in experimental atopic dermatitis and psoriasis. ( 28530223 )
2017
9
Allergic contact dermatitis caused by exfoliating socks. ( 27957756 )
2017
10
Preliminary evaluation of cytosine-phosphate-guanine oligodeoxynucleotides bound to gelatine nanoparticles as immunotherapy for canine atopic dermatitis. ( 28526774 )
2017
11
OBESITY AND ATOPIC DERMATITIS, ALLERGIC RHINITIS. ( 28904285 )
2017
12
Skin targeting of curcumin solid lipid nanoparticles-engrossed topical gel for the treatment of pigmentation and irritant contact dermatitis. ( 28884598 )
2017
13
A first case of erythema multiforme-like contact dermatitis caused by propolis. ( 28872200 )
2017
14
Clinical features of shiitake dermatitis: a systematic review. ( 28054338 )
2017
15
High Staphylococcus epidermidis Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis. ( 28685715 )
2017
16
Comparison of different regimens of pimecrolimus 1% cream in the treatment of facial seborrheic dermatitis. ( 28589618 )
2017
17
Allergic contact dermatitis caused by resorcinol following a temporary black henna tattoo. ( 28766804 )
2017
18
Allergic contact dermatitis caused by benzoic acid and lauryl glucoside in a sunscreen. ( 28766797 )
2017
19
Reactive granulomatous dermatitis presenting as subcutaneous nodules and cords in a patient with advanced myelodysplastic syndrome. ( 28220192 )
2017
20
Interstitial granulomatous dermatitis during talimogen laherparepvec treatment. ( 28570389 )
2017
21
CD1c+ Blood Dendritic Cells in Atopic Dermatitis are Premature and Can Produce Disease-specific Chemokines. ( 27701668 )
2017
22
Atopic Dermatitis, The Skin-Disease. ( 28905494 )
2017
23
Allergic contact dermatitis caused by a moisturizer containing iodopropynyl butylcarbamate. ( 28940475 )
2017
24
Altered Expression of Genes Encoding Cornulin and Repetin in Atopic Dermatitis. ( 28219068 )
2017
25
The frequency of urinary tract infection and subclinical bacteriuria in dogs with allergic dermatitis treated with oclacitinib: a prospective study. ( 28513001 )
2017
26
Palisaded Neutrophilic and Granulomatous Dermatitis/Interstitial Granulomatous Dermatitis Overlap: A Striking Clinical and Histologic Presentation With "Burning Rope Sign" and Subsequent Mirror-Image Contralateral Recurrence. ( 28475518 )
2017
27
Outbreak of Occupational Dermatitis Associated With Pyemotes ventricosus. ( 28445563 )
2017
28
Autoimmune progesterone dermatitis manifesting as mucosal erythema multiforme in the setting of HIV infection. ( 28050592 )
2017
29
RF-Itraconazole Pulse Therapy for Seborrheic Dermatitis: A Treatment Approach to Consider. ( 28262107 )
2017
30
Treatment of Seborrheic Dermatitis Using a Novel Herbal-based Cream. ( 28458770 )
2017
31
Haplotype dependent association of rs7927894 (11q13.5) with atopic dermatitis and chronic allergic rhinitis: A study in ECAP cohort. ( 28886043 )
2017
32
Expression of keratin 1, keratin 10, desmoglein 1 and desmocollin 1 in the epidermis: possible downregulation by interleukin-4 and interleukin-13 in atopic dermatitis. ( 28524044 )
2017
33
TLR7/8 agonists stimulate plasmacytoid dendritic cells to initiate a Th17-deviated acute contact dermatitis in humans. ( 28935206 )
2017
34
Contact allergy to lanolin: temporal changes in prevalence and association with atopic dermatitis. ( 28940210 )
2017
35
Wet Wipe Allergens: Retrospective Analysis From the North American Contact Dermatitis Group 2011-2014. ( 28002231 )
2017
36
Three Cases of Autoimmune Progesterone Dermatitis. ( 28761298 )
2017
37
Chronic Granulomatous Dermatitis Induced by Talimogene Laherparepvec Therapy of Melanoma Metastases. ( 28940544 )
2017
38
Erosive pustular dermatosis of the scalp after contact dermatitis from a prosthetic hair piece. ( 28331897 )
2017
39
Serum levels and tissue expression of interleukin-31 in dermatitis herpetiformis and bullous pemphigoid. ( 28465041 )
2017
40
Improved transdermal delivery of morin efficiently inhibits allergic contact dermatitis. ( 28739503 )
2017
41
Atopic dermatitis: Burden of illness, quality of life, and associated complications. ( 28052794 )
2017
42
Parental knowledge, attitude, and behavior toward children with atopic dermatitis. ( 28083974 )
2017
43
Enhanced expression of genes related to xenobiotic metabolism in the skin of patients with atopic dermatitis but not with ichthyosis vulgaris. ( 28899689 )
2017
44
Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. ( 28932705 )
2017
45
The nutrition of poultry as a factor affecting litter quality and foot pad dermatitis - an updated review. ( 28066939 )
2017
46
Dermatitis herpetiformis (Duhring's disease): a therapeutic challenge. ( 28497492 )
2017
47
Contact Dermatitis Associated with Alopecia and Hyperpigmentation. ( 28884901 )
2017
48
Elevated fecal calprotectin levels are associated with severity of atopic dermatitis in children. ( 28938841 )
2017
49
Comorbidities of Atopic Dermatitis: Beyond Rhinitis and Asthma. ( 28890845 )
2017
50
Chronic Allergic Contact Dermatitis Due to Chlorhexidine. ( 28939138 )
2017

Variations for Dermatitis

Expression for Dermatitis

Search GEO for disease gene expression data for Dermatitis.

Pathways for Dermatitis

GO Terms for Dermatitis

Cellular components related to Dermatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.56 CCL11 CCL17 CCL22 CCL27 IL13 IL31
2 external side of plasma membrane GO:0009897 9.46 IGHE IL13 IL31RA IL4
3 extracellular region GO:0005576 9.4 CCL11 CCL17 CCL22 CCL27 CMA1 FAF2

Biological processes related to Dermatitis according to GeneCards Suite gene sharing:

(show all 22)
id Name GO ID Score Top Affiliating Genes
1 cell-cell signaling GO:0007267 9.9 CCL17 CCL22 CCL27 IL13
2 cellular response to tumor necrosis factor GO:0071356 9.78 CCL11 CCL17 CCL22
3 cornification GO:0070268 9.77 DSG1 FLG SPINK5
4 positive regulation of ERK1 and ERK2 cascade GO:0070374 9.76 CCL11 CCL17 CCL22 NOD2
5 cellular response to interleukin-1 GO:0071347 9.74 CCL11 CCL17 CCL22
6 chemokine-mediated signaling pathway GO:0070098 9.73 CCL11 CCL17 CCL22
7 regulation of inflammatory response GO:0050727 9.72 CMA1 IL4 NOD2
8 positive regulation of B cell activation GO:0050871 9.71 IGHE IL4 NOD2
9 neutrophil chemotaxis GO:0030593 9.69 CCL11 CCL17 CCL22
10 cellular response to interferon-gamma GO:0071346 9.61 CCL11 CCL17 CCL22
11 microglial cell activation GO:0001774 9.58 IL13 IL4
12 positive regulation of mast cell degranulation GO:0043306 9.58 IL13 IL4
13 monocyte chemotaxis GO:0002548 9.58 CCL11 CCL17 CCL22
14 positive regulation of immunoglobulin production GO:0002639 9.52 IL13 IL4
15 positive regulation of tyrosine phosphorylation of STAT protein GO:0042531 9.49 IL31RA IL4
16 negative regulation of macrophage activation GO:0043031 9.48 IL31RA IL4
17 regulation of proton transport GO:0010155 9.37 IL13 IL4
18 chemotaxis GO:0006935 9.35 CCL11 CCL17 CCL22 CCL27 IL4
19 lymphocyte chemotaxis GO:0048247 9.33 CCL11 CCL17 CCL22
20 negative regulation of complement-dependent cytotoxicity GO:1903660 9.32 IL13 IL4
21 T-helper 2 cell cytokine production GO:0035745 9.26 IL31RA IL4
22 immune response GO:0006955 9.17 CCL11 CCL17 CCL22 CCL27 IGHE IL13

Molecular functions related to Dermatitis according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 CCR chemokine receptor binding GO:0048020 9.26 CCL17 CCL22
2 chemokine activity GO:0008009 9.26 CCL11 CCL17 CCL22 CCL27
3 cytokine activity GO:0005125 9.17 CCL11 CCL17 CCL22 IL13 IL31 IL4
4 CCR3 chemokine receptor binding GO:0031728 9.16 CCL11 CCL27

Sources for Dermatitis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....